Weber, Martin S., Prof. Dr.

2003 Dr. med., Medical School of the University of Würzburg, Germany
2002–2004 Residency in Neurology, Postdoctoral-fellowship, Institute of Clinical Neuroimmunology (Prof. Dr. R. Hohlfeld) and Department of Neurology (Prof. Dr. Th. Brandt) Ludwig-Maximilians University, Munich-Großhadern; Max-Planck-Institute for Neurobiology (Prof. Dr. H. Wekerle), Germany
2004–2007 Postdoctoral-fellowship at the University of California, San Francisco, USA; Department of Neurology (Prof. Dr. S. Hauser), Laboratory of Prof. Dr. S. Zamvil
2008–02/2011 Senior Scientist, Residency in Neurology, Department of Neurology (Prof. Dr. B. Hemmer), Technische Universität München, Munich, Germany
03/2011 Reasearch group leader and board-certified Neurologist, since 10/2012
09/2012 Habilitation (professorial qualification) and Venia legendi for Neurology, Department of Neurology, Technische Universität München, Munich, Germany
since 10/2012 ProFutura Research group leader at the Institute of Neuropathology (Prof. Dr. W. Brück), University Medical Center, Göttingen, Germany
since 04/2013 Senior physician (“Oberarzt”) at the Department of Neurology (Prof. Dr. M. Bähr), University of Göttingen, Germany, head of the neuroimmunology unit, University Medical Center, Göttingen, Germany
07/2013-12/2017 appointed W2 Professor (tenure track) for „Translational Neuroinflammation“, University Medical Center, Göttingen, Germany
since 09/2016 Deputy head of the Laboratory for neurochemical analyses (including cerebrospinal fluid diagnostic), University Medical Center, Göttingen, Germany
since 04/2017 appointed Head of the interdisciplinary “Multiple Scerosis Center Göttingen”, University Medical Center, Göttingen, Germany
since 01/2018 Tenured W2 Professor for „Translational Neuroinflammation”, University Medical Center, Göttingen, Germany
since 10/2018 Managing Senior Physician “Geschäftsführender Oberarzt”, University Medical Center, Göttingen, Germany

Major Research Interests
Dr. Weber’s research focuses on the role of antigen-presenting cells and B cells in Multiple Sclerosis and its experimental models. His primary interest is to elucidate the functional diversity of different phenotypes of B cells and antigen-presenting cells and to understand how these findings can be harnessed to accelerate therapeutic innovation in Multiple Sclerosis.

Homepage Department/Research Group
https://neuropathologie.umg.eu/forschung/arbeitsgruppen-labore/ag-martin-weber/

ORCID: 0000-0001-8409-0389